{'fraction_non_alphanumeric': 0.030634573304157548, 'fraction_numerical': 0.0, 'mean_word_length': 4.941558441558442, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Clinical application and mechanism of botulinum toxin type A in scar treatment].

Pathological scars cause both local physical discomforts and mental disorders for patients. With the development of research, botulinum toxin type A (BTX-A) has been gradually used in the clinical treatment of scars. This article summarizes three potential mechanism of BTX-A, including early tension reduction, inhibition of connective tissue hyperplasia, and alleviation of local inflammation, as well as the clinical application of BTX-A in different types of scars. However, there is no uniform standard for the time, method, and ratio of BTX-A injection for scar treatment, and there is also a lack of long-term follow-up results. Further researches are needed to clarify the mechanism of BTX-A in inhibiting scar. Uniform protocol of BTX-A injection is yet to be established to provide more efficient treatment plan for scar.